Affiliation:
1. Department of Clinical Pharmacology, University Hospital of Monastir The University of Monastir Monastir Tunisia
2. Department of Neurosurgery, University Hospital of Monastir The University of Monastir Monastir Tunisia
3. Department of Medical Imaging, University Hospital of Monastir The University of Monastir Monastir Tunisia
Abstract
AbstractThe safety profile of the Sputnik V vaccine is generally reassuring. Nevertheless, an enhanced risk of new‐onset of immune‐mediated diseases has been increasingly reported following the adenoviral‐based Covid‐19 vaccine, including inflammatory arthritis, Guillain‐Barré syndrome, optical neuromyelitis, acute disseminated encephalomyelitis, subacute thyroiditis and acute liver injury as well as glomerulopathy. However, no case of autoimmune pancreatitis has been reported yet. Herein, we describe a case of type I autoimmune pancreatitis that may be due to the Sputnik V Covid‐19 vaccine.
Subject
Pharmacology (medical),Pharmacology
Reference27 articles.
1. Active monitoring of early safety of sputnik V vaccine in Buenos Aires, Argentina;Pagotto V;Medicina (Mex),2021
2. Post COVID-19 vaccination neuromyelitis optica spectrum disorder: Case report & MRI findings
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献